Methods for identifying small molecules that modulate...

Details Methods for identifying small molecules that modulate... Methods for identifying small molecules that modulate...

2007-11-06

2007-11-06

Whisenant, Ethan (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023100, C536S024300

Reexamination Certificate

active

10519243

ABSTRACT:
The present invention relates to methods for identifying compounds that modulate premature translation termination and/or nonsense-mediated mRNA decay by screening and identifying compounds that modulate the post-transcriptional expression of any gene with a premature translation stop codon. The invention particularly relates to using any gene encoding a premature stop codon to identify compounds that modulate premature translation termination and/or nonsense-mediated mRNA decay. A compound that modulates premature translation termination and/or nonsense-mediated mRNA decay of a target gene is identified using standard methods known in the art to measure changes in translation or mRNA stability of the gene product or mRNA of the gene with the premature stop codon. The methods of the present invention provide a simple, sensitive assay for high-throughput screening of libraries of compounds to identify pharmaceutical leads.

REFERENCES:
patent: 4668625 (1987-05-01), Cambiaghi et al.
patent: 5015570 (1991-05-01), Scangos et al.
patent: 5510240 (1996-04-01), Lam et al.
patent: 5593835 (1997-01-01), Rando et al.
patent: 5641627 (1997-06-01), Moehle
patent: 5650316 (1997-07-01), Aggarwal et al.
patent: 5663317 (1997-09-01), Falkow et al.
patent: 5666341 (1997-09-01), Horibe et al.
patent: 5667975 (1997-09-01), Dykstra et al.
patent: 5679566 (1997-10-01), He et al.
patent: 5712096 (1998-01-01), Stern et al.
patent: 5716825 (1998-02-01), Hancock et al.
patent: 5807682 (1998-09-01), Grossman et al.
patent: 5840702 (1998-11-01), Bedwell
patent: 5866341 (1999-02-01), Spinella et al.
patent: 5871923 (1999-02-01), Moehle
patent: 6004749 (1999-12-01), Giordano et al.
patent: 6060240 (2000-05-01), Kamb et al.
patent: 6071700 (2000-06-01), He et al.
patent: 6090912 (2000-07-01), Lebl et al.
patent: 6107029 (2000-08-01), Giordano
patent: 6147344 (2000-11-01), Annis et al.
patent: 6207391 (2001-03-01), Wu et al.
patent: 6211477 (2001-04-01), Cardott et al.
patent: 6232075 (2001-05-01), Williams
patent: 6320040 (2001-11-01), Cook et al.
patent: 6329146 (2001-12-01), Crooke et al.
patent: 6355428 (2002-03-01), Schroth et al.
patent: 6391542 (2002-05-01), Anderson et al.
patent: 6458538 (2002-10-01), Beckmann et al.
patent: 6503713 (2003-01-01), Rana
patent: 6503721 (2003-01-01), Arenas et al.
patent: 6596481 (2003-07-01), Rothschild et al.
patent: 6992096 (2006-01-01), Karp et al.
patent: 7026122 (2006-04-01), Beckmann et al.
patent: 2003/0232360 (2003-12-01), Wilusz et al.
patent: 2004/0067900 (2004-04-01), Wilde et al.
patent: 2006/0134681 (2006-06-01), Beckmann et al.
patent: 2006/0166926 (2006-07-01), Wilde et al.
patent: 2006/0167065 (2006-07-01), Wilde et al.
patent: 2006/0167623 (2006-07-01), Wilde et al.
patent: WO 97/09342 (1997-03-01), None
patent: WO 99/20797 (1999-04-01), None
patent: WO 01/44516 (2001-06-01), None
patent: WO 2004/010106 (2004-01-01), None
Andreutti-Zaugg, C. et al., “Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques,”Cancerr Research1997; 57(15): 3288-3293.
Barton-Davis et al., “Animoglycoside antibiotics restore dystrophin function to skeletal muscles ofmdxmice”J. of Clin. Invesy. Aug. 1999; 104(4): 375-381.
Bateman J.F. et al., “Reliable and sensitive detection of premature termination mutations using a protein truncation test designed to overcome problems of nonsense-mediated mRNA instability.”Human Mutation1999; 13(4): 311-317.
Bedwell et al., “Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.”Nat. Med. Nov. 1997; 3(11): 1280-1284.
Burbaum J.J. & Siga, N.H. et al., “New technologies for high-throughput screening,”Curr. Opin. in Chem. Bio.; 72-78.
Buzina, A. & Shulman, M.J., “Infrequent Translation of a Nonsense Codon is sufficient to decrease mRNA Level.”Mol. Bio. of the CellMar. 1999; 10: 515-524.
Carter et al., “A Regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro”The J. of Biol. Chem.. 1996, 270(48):28995-29003.
Carter et al.., “A splicing-dependent regulatory mechanism that detects translation signals.”The EMBO Journal1996; 15(21): 5965-5975.
Culbertson, M.R., “Unforeseen consequences for gene expression, inherited genetic disorder and cancer.”TIG Nat. Med. Feb. 1999; 15(2): 74-80.
Cundliffe et al., “How antibiotic-producing organisms avoid suicide.”Ann. Rev. Microbiol. 1989; 43:207-233.
Cundliffe et al., “The Ribosome: Structure, Function, & Evolution.” Schlessinger et al., eds. American Society for Microbiology, Washington D.C. 1990; pp. 479-490.
Darling, T. N. et al., “Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.”J. of Invest. Derm. 1998 Febl; 110(2): 165-169.
Darling, T.N. et al, Premature Termination Codons are present on both alleles of the Bullous Pemphigoid Antigen 2/Type XVIII Collagen Gene in Five Austrian Families with Generallized Atrophic Benign Epidermolysis Bullosa,J. Invest. Derm.. Apr. 1997; 108(4): 463-468.
Dinman, J.D. et al., “Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents.”Tibtech(reviews) Apr. 1998; 16:190-196.
Garvin, A.M., “A complete protein truncation test for BRCA1 and BRCA2.”Euro. J. of Human Gene.. May 1998; 6(3): 226-234.
Hentze, M.W. & Kulozik, A.E. “A Perfect Message: RNA Surveillance and Nonsense-Mediated Decay”CellFeb. 1999; 96: 307-310.
Howard et al., “Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.”Nat. Med. Apr. 1996; 2(4): 467-46.
Hutchin et al., “A molecular basis for human hypersensitivity to aminoglycoside antibiotics”Nucl. Acids Res1993; 21(18):4174-4179.
Jackson, R.J. & Hunt, T. “Preparation and Use of Nuclease-Treated Rabbit Reticulocyte Lysates for the Translation of Eukaryotic Messenger RNA.”Meths. in Enzymol. 1983; 96: 50-75.
Li, S. & Wilkinson, F., “Nonsense Surveillance in Lymphocytes?”ImmunityFeb. 1998; 8: 135-141.
Purohit et al., “Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit”Nature1994; 370(6491):659-662.
Ruiz-Echevarria et al., “Making sense of nonsense in yeast”TIBSNov. 1996; 21: 433-438.
Stage et al., “Inhibition of the hammerhead ribozyme by neomycin”RNA1995; 1(1):95-101.
Von Ahsen et al., “Antibiotic inhibition of group I ribozyme function.”Nature(London) 1991; 353(6342):368-370.
Woodcock et al., “Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA”EMBO J. 1991; 10:3099-3103.
Zapp et al. “Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production”Cell1993; 74(6):969-978.
Aboul-Ela et al., “The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.”J. Mol. Biol. 1995; 253:313-332.
Aggarwal et al., “Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor, TNF, gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells.”Cancer Res. 1996; 56:5156-5164.
Bakheet et al., “ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.”Nucleic Acids Res. 2001; 29:246-254.
Bayer, “Towards The Chemical Synthesis of Proteins.”Angew. Chem. 1991; 30:113-129.
Beal & Dervan, “Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formatio

Affiliated with

Also associated with

Rating

Methods for identifying small molecules that modulate... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying small molecules that modulate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying small molecules that modulate... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3835352